Venture Financing 11
Euroscreen Raises USD17.8 Million in Series B Financing Round 11
Euroscreen Raises US $ 13 Million In Series A Financing 12
Licensing Agreements 13
Euroscreen Enters into Licensing Agreement with Merck 13
Euroscreen Enters Into Licensing Agreement With Ortho-McNeil-Janssen 14
Acquisition 15
Astellas Pharma to Acquire Ogeda for up to USD852 Million 15
Ogeda SA- Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Mar 04, 2016: Euroscreen Strengthens its Management Team 20
Product Approvals 21
Jul 19, 2016: EUROSCREEN opens US-IND for ESN364 on three Phase II trials 21
Clinical Trials 22
Sep 14, 2016: Euroscreen SA: Completes Enrollment in Phase II trial of lead candidate ESN364 in Menopausal Hot Flashes 22
Other Significant Developments 23
Oct 19, 2016: Euroscreen announces name change to Ogeda 23
Appendix 24